Efficacy of dexamethasone added to ramosetron for preventing postoperative nausea and vomiting in highly susceptible patients following spine surgery
Open Access
- 1 January 2012
- journal article
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 62 (3) , 260-265
Abstract
Opioid-based patient controlled analgesia (PCA) provides adequate pain control following spinal surgeries at the expense of increased risk of postoperative nausea and vomiting (PONV). We evaluated the efficacy of dexamethasone added to ramosetron, which is a newly developed five-hydroxytryptamine receptor 3 antagonist with a higher receptor affinity and longer action duration compared to its congeners, on preventing PONV in highly susceptible patients receiving opioid-based IV PCA after spinal surgery. One hundred nonsmoking female patients undergoing spinal surgery were randomly allocated to either a ramosetron group (group R) or a ramosetron plus dexamethasone group (group RD)., Normal saline (1 ml) or 5 mg of dexamethasone was injected before anesthetic induction, while at the end of the surgery, ramosetron (0.3 mg) was administered to all patients and fentanyl-based IV PCA was continued for 48 hrs. The incidence and severity of PONV, pain score and the amount of rescue antiemetics were assessed for 48 hours after surgery. The number of patients with moderate to severe nausea (20 vs. 10, P = 0.029), and overall incidence of vomiting (13 vs. 5, P = 0.037) were significantly lower in the group RD than in the group R, respectively. Rescue antiemetic was used less in the RD group without significance. Combination of ramosetron and dexamethasone significantly reduced the incidence of moderate to severe nausea and vomiting compared to ramosetron alone in highly susceptible patients receiving opioid-based IV PCA after surgery.Keywords
This publication has 28 references indexed in Scilit:
- Effect of Ramosetron on Patient-Controlled Analgesia Related Nausea and Vomiting After Spine Surgery in Highly Susceptible PatientsSpine, 2008
- Efficacy and complications of patient-controlled analgesia treatment after spinal surgerySurgical Neurology, 2007
- Ondansetron and Dexamethasone Dose Combinations for Prophylaxis Against Postoperative Nausea and VomitingAnesthesia & Analgesia, 2007
- The Efficacy of 5-HT3 Receptor Antagonists for the Prevention of Postoperative Nausea and Vomiting After Craniotomy: A Meta-AnalysisJournal of Neurosurgical Anesthesiology, 2007
- Postoperative Pain Control using Intravenous Patient Controlled Analgesia in Cesarean Section and HysterectomyKorean Journal of Anesthesiology, 2007
- Combination of Antiemetics for the Prevention of Postoperative Nausea and Vomiting in High-Risk PatientsJournal of Korean Medical Science, 2007
- Multicenter, randomized trial of ramosetron plus dexamethasone versus ramosetron alone in controlling cisplatin-induced emesisSupportive Care in Cancer, 2004
- A Comparison of Three Antiemetic Combinations for the Prevention of Postoperative Nausea and VomitingAnesthesia & Analgesia, 2002
- Combination therapy for postoperative nausea and vomiting — a more effective prophylaxis?Ambulatory Surgery, 2001
- Halothane for controlled hypotension in back surgeryCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1967